Table 2.
Clinicopathological characteristics of patients with non-small cell lung cancer (NSCLC) and noncancerous lung tissues in the tissue arrays
| SCC (n=129) | ADC (n=129) | |||
|---|---|---|---|---|
| Characteristics | No. of patients (%) | Characteristics | No. of patients (%) | |
| Age(years) | Age(years) | |||
| ≤50 | 31(24.0) | ≤50 | 36(27.9) | |
| >50 | 98(76.0) | >50 | 93(72.1) | |
| Gender | Gender | |||
| Male | 118(91.5) | Male | 76(58.9) | |
| Female | 11(8.5) | Female | 53(41.1) | |
| Clinical stages | Clinical stages | |||
| Stage I | 29(22.5) | Stage I | 40(31.0) | |
| Stage II | 29(22.5) | Stage II | 27(20.9) | |
| Stage III | 63(48.8) | Stage III | 54(41.9) | |
| Stage IV | 8(6.2) | Stage IV | 8(6.2) | |
| LNM status | LNM status | |||
| N0 | 57(44.2) | N0 | 53(41.1) | |
| N1/N2/N3 | 72(55.8) | N1/N2/N3 | 76(58.9) | |
| Differentiation | Differentiation | |||
| Well | 3(2.3) | Well | 2(1.6) | |
| Moderate | 56(43.4) | Moderate | 57(44.2) | |
| Poor | 70(54.3) | Poor | 70(54.3) | |
| Survival status | Survival status | |||
| Live | 82(63.6) | Live | 74(57.4) | |
| Death | 47(36.4) | Death | 55(42.6) | |
| Non-cancerous lung tissues (n=49) | ||||
| Age (years) | Gender | |||
| ≤50 | 39(79.6) | Male | 25(51.0) | |
| >50 | 10(20.4) | Female | 24(49.0) | |